Knoll Capital Management, LLC Diversified Active

Location: Miami, FL

CIK: 0001325083 · Show all filings

Period: Q3 2014 (← Previous) (Next →)

Filing Date: Dec 9, 2014

Total Value: $257M

Holdings (15)

— Medivation, Inc. 86.3%

Value $222M Shares 2,244,519 Est. Cost $49.20 Unrealized —

— Ampio Pharmaceuticals Inc. 4.7%

Value $12M Shares 3,370,822 Est. Cost $6.03 Unrealized —

— Alcobra Ltd 4.1%

Value $10.61M Shares 687,000 Est. Cost $8.47 Unrealized —

— Keryx Biopharmaceuticals Inc. 1.1%

Value $2.75M Shares 200,000 Est. Cost $10.21 Unrealized —

— Bio Blast Pharma Ltd 1.0%

Value $2.458M Shares 338,110 Est. Cost $7.27 Unrealized —

— Synthetic Biologics Inc. 0.9%

Value $2.394M Shares 1,360,000 Est. Cost $1.51 Unrealized —

— Newlink Genetics Corp 0.6%

Value $1.659M Shares 77,437 Est. Cost $19.35 Unrealized —

— Inovio Pharmaceuticals Inc. 0.4%

Value $1.006M Shares 102,088 Est. Cost $10.86 Unrealized —

— Advaxis Inc. 0.3%

Value $756K Shares 225,000 Est. Cost $3.36 Unrealized —

— Galmed Pharmaceuticals Ltd 0.2%

Value $559K Shares 65,000 Est. Cost $11.48 Unrealized —

NWBO Northwest Biotherapeutics Inc 0.1%

Value $337K Shares 67,035 Est. Cost $5.93 Unrealized +3.7%

— Nephrogenex Inc 0.1%

Value $234K Shares 50,000 Est. Cost $8.24 Unrealized —

PVCT Provectus Biopharmaceuticals 0.1%

Value $204K Shares 200,000 Est. Cost $1.90 Unrealized -48.9%

— Advaxis Inc. 0.1%

Value $162K Shares 112,500 Est. Cost $1.44 Unrealized —

— Cellectar Biosciences Inc 0.0%

Value $33,000 Shares 14,634 Est. Cost $2.26 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Medivation, Inc.	2,244,519	$222M	86.3%	$49.20	—	—	58501N101
—	Ampio Pharmaceuticals Inc.	3,370,822	$12M	4.7%	$6.03	—	—	03209T109
—	Alcobra Ltd	687,000	$10.61M	4.1%	$8.47	—	—	M2239P109
—	Keryx Biopharmaceuticals Inc.	200,000	$2.75M	1.1%	$10.21	—	—	492515101
—	Bio Blast Pharma Ltd	338,110	$2.458M	1.0%	$7.27	—	—	M20156101
—	Synthetic Biologics Inc.	1,360,000	$2.394M	0.9%	$1.51	—	—	87164U102
—	Newlink Genetics Corp	77,437	$1.659M	0.6%	$19.35	—	—	651511107
—	Inovio Pharmaceuticals Inc.	102,088	$1.006M	0.4%	$10.86	—	—	45773H201
—	Advaxis Inc.	225,000	$756K	0.3%	$3.36	—	—	007624208
—	Galmed Pharmaceuticals Ltd	65,000	$559K	0.2%	$11.48	—	—	M47238106
NWBO	Northwest Biotherapeutics Inc	67,035	$337K	0.1%	$5.93	+3.7%	—	66737P600
—	Nephrogenex Inc	50,000	$234K	0.1%	$8.24	—	—	640667101
PVCT	Provectus Biopharmaceuticals	200,000	$204K	0.1%	$1.90	-48.9%	—	74373P108
—	Advaxis Inc.	112,500	$162K	0.1%	$1.44	—	—	007624117
—	Cellectar Biosciences Inc	14,634	$33,000	0.0%	$2.26	—	—	15117F203